Activation of RTKs and downstream PI3K signaling have been implicated in acceleration of tumour growth, malignant transformation, and resistance in different cancers (Zhang et al., 2007; Jung et al., 2015; Starska et al., 2018). This evidence concerns the gene PIK3CG and cancer.